different glp-1 agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes GLP-1 receptor agonists for individualized

GLP-1 Examples A 2023 update 6 tells us there are currently seven GLP-1 receptor agonists, including: Exenatide Brand name: Byetta Dosage: twice-daily injection Exenatide extended-release Brand name: Bydureon Dosage: once-weekly injection Lixisenatide Brand name: Adlyxin Dosage: once-daily injection Liraglutide Brand names: Victoza and Saxenda Dosage: once-daily injection Dulaglutide Brand names: Trulicity Dosage: once-weekly injection Semaglutide Brand names: Ozempic and Wegovy Dosage: once-weekly injection Oral semaglutide Brand name: Rybelsus Dosage: once-daily injection We also can't overlook tirzepatide (branded as Mounjaro), which is the first agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors

Esser, J.-P

Antioxidant defenses and glutathione The reality of oxidative stress is demonstrated by the existence, in all aerobic organisms, of several antioxidant enzymes devoted to ROS detoxification, such as peroxidase, catalase, superoxide dismutase, and peroxiredoxins

G-6-PD deficiency is the most common known enzymopathy with around 400 million people affected worldwide